Regulations/Legal

Latest Issue of OR Manager
January 2025
Home Regulations/Legal

Immunogenicity of COVID-19 vaccines in pregnant, lactating women

Editor's Note This study from Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, finds that COVID-19 mRNA vaccines are immunogenic in pregnant and lactating women, and they induce immune responses against variants. For the study, researchers enrolled 30 pregnant, 16 lactating, and 57 neither pregnant nor lactating women…

Read More

By: Judy Mathias
May 13, 2021
Share

FDA: BD recalls certain lots of ChloraPrep

Editor's Note The Food & Drug Administration announced on April 20 that Becton, Dickinson and Company (BD) was recalling certain lots of its ChloraPrep Hi-Lite Orange 26 mL Applicator. ChloraPrep is used as an antiseptic to prepare a patient’s skin before surgery. The recall was initiated because the Applicator, which…

Read More

By: Judy Mathias
May 11, 2021
Share

Effectiveness of adding mask recommendations to other COVID-19 public health measures

Editor's Note This randomized, controlled trial by Danish researchers finds that wearing surgical masks to supplement other public health measures did not significantly reduce the COVID-19 infection rate, compared with no mask. Of 6,024 trial participants, 3,030 were randomly assigned to wear high-quality surgical face masks with a filtration rate…

Read More

By: Judy Mathias
May 6, 2021
Share

COVID-19 cases at 7-month low

Editor's Note The US averaged 48,000 new COVID-19 cases per day in the past week. This is a 15% improvement from last week, and the first time since October 2020 that average daily cases have fallen below 50,000. Nationally, deaths from COVID-19 fell 3% to 4,819, the fewest deaths in…

Read More

By: Judy Mathias
May 6, 2021
Share

Sponsored Message

Performance of disposable vs reusable cover gowns

Editor's Note In this study, led by researchers at Florida State University, Tallahassee, reusable cover gowns were found to provide increased protection, compared to disposable cover gowns. During personal protective equipment (PPE) shortages, such as during the COVID-19 pandemic, the Centers for Disease Control and Prevention recommends that washable cloth…

Read More

By: Judy Mathias
May 6, 2021
Share

Hospira recalls one lot each of 0.5% Bupivacaine and 1% Lidocaine because of mislabeling

Editor's Note Hospira Inc, a Pfizer company, announced May 4 that it is recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCL Injection, USP 30 mL because of mislabeling. A portion of each lot was incorrectly labeled as the other product.…

Read More

By: Judy Mathias
May 6, 2021
Share

Sponsored Message

US deficit in cancer screening associated with COVID-19

Editor's Note This study led by researchers at the University of Kansas Medical Center, Kansas City, finds a sharp decline in breast, colorectal, and prostate cancer screening rates in 2020. This analysis of data on 60 million people in Medicare Advantage and commercial health plans across the US shows that…

Read More

By: Judy Mathias
May 5, 2021
Share

NIOSH revokes emergency approval of Plastikon's N95 masks

Editor's Note The National Institute for Occupational Safety and Health (NIOSH), on May 4, revoked its public health emergency approval for Plastikon Industries’ (Hayward, California) PLASMA N95-01 masks. The revocation was issued because a product audit by NIOSH failed to meet filter efficiency requirements. The mask is no longer approved…

Read More

By: Judy Mathias
May 5, 2021
Share

Effect of COVID-19 stay-at-home order on opioid overdose fatalities

Editor's Note In this report, researchers from Northwestern University Feinberg School of Medicine, Chicago, estimate the number of opioid-involved overdose deaths in Cook County over a 3-year period to highlight changes, before, during, and after the Illinois COVID-19 stay-at-home order. From January 2018 to December 2020, 4,283 overdose fatalities occurred…

Read More

By: Judy Mathias
May 4, 2021
Share

FDA: Class I recall of Alaris Infusion Pump Module 8100

Editor's Note The Food and Drug Administration, on April 30, identified the recall of the Alaris Infusion Pump Module 8100 as Class I, the most serious. The Pacific Medical Group (DBA Avante Health Solutions) is recalling the infusion pump because the front bezel components may crack or separate, leading to…

Read More

By: Judy Mathias
May 3, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat